More about
Ras-Mutant Metastatic Colorectal Cancer
News
October 16, 2020
2 min read
Save
Adding bevacizumab to chemotherapy increases resectability of colorectal liver metastases
The addition of bevacizumab to modied FOLFOX6 improved liver metastases resection rates and survival outcomes among certain patients with colorectal liver metastases, according to study results published in Journal of Clinical Oncology.